Clinical Trials Logo
  1. Home
  2. Cystoid Macular Edema
  3. NCT00406172
  4. Details
NCT00406172 Clinical Trial

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Cystoid Macular Edema Clinical Trial

Official title:
Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT00406172
Other study ID # APEC 0016
Secondary ID
Status Withdrawn
Phase Phase 3
First received
Last updated
Start date November 2006
Est. completion date November 2006

Study information
Verified date June 2024
Source Asociación para Evitar la Ceguera en México
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To report safety and efficacy of intravitreal injection of bevacizumab in patients with cystoid macular edema secondary to cataract surgery.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date November 2006
Est. primary completion date November 2006
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Pseudophakic eyes with macular edema Exclusion Criteria: - Other retinopathies

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Bevacizumab

Locations
Country Name City State
Mexico APEC México D.F.

Sponsors (1)
Lead Sponsor Collaborator
Asociación para Evitar la Ceguera en México

Country where clinical trial is conducted

Mexico, 

See also
  Status Clinical Trial Phase
Completed NCT00508040 - Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a Phase 2
Terminated NCT00114062 - Study to Treat Uveitis Associated Macular Edema Phase 2
Completed NCT03025945 - Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo N/A
Completed NCT01978015 - Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG Phase 4
Recruiting NCT05158699 - Effectiveness of Periocular Drug Injection in CATaract Surgery Phase 3
Withdrawn NCT02598869 - Posterior Subtenon Versus Intravitreal Injection of Triamcinolone Acetonide for Treatment of Uveitic Cystoid Macular Edema Phase 4
Terminated NCT04527523 - Descemet Membrane Endothelial Keratoplasty vs. Descemet's Stripping With Endothelial Keratoplasty vs. Descemet Stripping Only
Completed NCT02294656 - Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide Phase 1
Not yet recruiting NCT04856670 - Assessing Diabetes Mellitus on Cytokine Analysis and Macular Edema Following FLACS
Completed NCT02609165 - Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema Phase 2
Withdrawn NCT00438243 - Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema. Phase 2
Completed NCT00464581 - Lucentis for Treatment of Macular Edema N/A
Active, not recruiting NCT03465124 - Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery N/A
Recruiting NCT02486484 - Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection Phase 2
Completed NCT00790803 - Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema N/A
Recruiting NCT04225611 - Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema Phase 1/Phase 2
Completed NCT05832996 - Cool vs Room-temperature Artificial Tears Phase 4
Completed NCT05615805 - The Effect of Ocular Rinse Volume on Surface Irritation After Intravitreal Injections N/A
Completed NCT00494494 - Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery Phase 4
Terminated NCT00346983 - Macugen to Prevent Worsening of Macular Edema Following Cataract Surgery in Diabetics Phase 1/Phase 2